REEP2
Basic information
Region (hg38): 5:138439057-138446969
Previous symbols: [ "C5orf19" ]
Links
Phenotypes
GenCC
Source:
- hereditary spastic paraplegia 72 (Moderate), mode of inheritance: Semidominant
- hereditary spastic paraplegia 72 (Supportive), mode of inheritance: AD
- hereditary spastic paraplegia 72 (Strong), mode of inheritance: AD
- hereditary spastic paraplegia 72 (Strong), mode of inheritance: AR
- hereditary spastic paraplegia 72 (Moderate), mode of inheritance: AD
- hereditary spastic paraplegia (Limited), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Spastic paraplegia 72A, autosomal dominant; Spastic paraplegia 72B, autosomal recessive | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 24388663 |
ClinVar
This is a list of variants' phenotypes submitted to
- Hereditary_spastic_paraplegia_72 (104 variants)
- Inborn_genetic_diseases (22 variants)
- not_provided (9 variants)
- not_specified (4 variants)
- REEP2-related_disorder (4 variants)
- Spastic_paraplegia_72b,_autosomal_recessive (3 variants)
- Hereditary_spastic_paraplegia_5A (1 variants)
- See_cases (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the REEP2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001271803.2. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 31 | 34 | ||||
| missense | 50 | 55 | ||||
| nonsense | 3 | |||||
| start loss | 1 | 1 | ||||
| frameshift | 1 | |||||
| splice donor/acceptor (+/-2bp) | 1 | |||||
| Total | 3 | 3 | 53 | 33 | 3 |
Highest pathogenic variant AF is 0.0000018593673
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| REEP2 | protein_coding | protein_coding | ENST00000254901 | 8 | 7953 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.439 | 0.559 | 125736 | 0 | 5 | 125741 | 0.0000199 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 1.64 | 103 | 161 | 0.638 | 0.0000102 | 1629 |
| Missense in Polyphen | 18 | 50.896 | 0.35367 | 559 | ||
| Synonymous | 0.520 | 65 | 70.6 | 0.921 | 0.00000506 | 511 |
| Loss of Function | 2.74 | 3 | 14.1 | 0.212 | 7.72e-7 | 156 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000289 | 0.0000289 |
| Ashkenazi Jewish | 0.000100 | 0.0000992 |
| East Asian | 0.0000544 | 0.0000544 |
| Finnish | 0.0000462 | 0.0000462 |
| European (Non-Finnish) | 0.00000880 | 0.00000879 |
| Middle Eastern | 0.0000544 | 0.0000544 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Required for endoplasmic reticulum (ER) network formation, shaping and remodeling. May enhance the cell surface expression of odorant receptors (By similarity). {ECO:0000250, ECO:0000269|PubMed:24388663}.;
- Pathway
- Signaling by GPCR;Signal Transduction;Olfactory Signaling Pathway;G alpha (s) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.129
- rvis_EVS
- -0.07
- rvis_percentile_EVS
- 48.12
Haploinsufficiency Scores
- pHI
- 0.351
- hipred
- Y
- hipred_score
- 0.731
- ghis
- 0.629
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.307
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Reep2
- Phenotype
Gene ontology
- Biological process
- regulation of intracellular transport;protein transport into membrane raft;sensory perception of bitter taste;sensory perception of sweet taste;endoplasmic reticulum tubular network organization
- Cellular component
- endoplasmic reticulum;endoplasmic reticulum membrane;cytoplasmic microtubule;integral component of plasma membrane
- Molecular function
- taste receptor binding